Arbaclofen placarbil
XenoPort has discontinued its potential spasticity treatment (a slow release version of baclofen) after a phase 3 trail showed it was no more effective than placebo. Reuters Spacticity - A to Z of MS (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - May 19, 2013 Category: Neurology Source Type: news

IV Baclofen Good for Spasm-Related Pain (CME/CE)
NEW ORLEANS (MedPage Today) -- Intravenous baclofen can effectively combat migraine and muscle spasm pain, researchers found. (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - May 10, 2013 Category: Psychiatry Source Type: news